BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20620690)

  • 1. [Chronic obstructive pulmonary disease and pneumonia].
    Huerta A; Domingo R; Soler N
    Arch Bronconeumol; 2010; 46 Suppl 3():28-31. PubMed ID: 20620690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease.
    Molinos L; Clemente MG; Miranda B; Alvarez C; del Busto B; Cocina BR; Alvarez F; Gorostidi J; Orejas C;
    J Infect; 2009 Jun; 58(6):417-24. PubMed ID: 19329187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infectious comorbidity in COPD].
    Jorge RZ; Bonilla AG
    Arch Bronconeumol; 2009; 45 Suppl 4():59-64. PubMed ID: 20116753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COPD is associated with increased mortality in patients with community-acquired pneumonia.
    Restrepo MI; Mortensen EM; Pugh JA; Anzueto A
    Eur Respir J; 2006 Aug; 28(2):346-51. PubMed ID: 16611653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
    File TM; Monte SV; Schentag JJ; Paladino JA; Klugman KP; Lavin B; Yu VL; Singer ME; Adelman MH
    Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of COPD on mortality and severity scoring in community-acquired pneumonia.
    Snijders D; van der Eerden M; de Graaff C; Boersma W
    Respiration; 2010; 79(1):46-53. PubMed ID: 19372638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.
    Pifarre R; Falguera M; Vicente-de-Vera C; Nogues A
    Respir Med; 2007 Oct; 101(10):2139-44. PubMed ID: 17629470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aetiology of, and risk factors for, recurrent community-acquired pneumonia.
    Garcia-Vidal C; Carratalà J; Fernández-Sabé N; Dorca J; Verdaguer R; Manresa F; Gudiol F
    Clin Microbiol Infect; 2009 Nov; 15(11):1033-8. PubMed ID: 19673961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
    Antonescu-Turcu AL; Tomic R
    Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Follow-up criteria for community acquired pneumonias and acute exacerbations of chronic obstructive pulmonary disease].
    Huchon G
    Med Mal Infect; 2006; 36(11-12):636-49. PubMed ID: 17137739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic vaccinations in chronic obstructive pulmonary disease: current status.
    Varkey JB; Varkey AB; Varkey B
    Curr Opin Pulm Med; 2009 Mar; 15(2):90-9. PubMed ID: 19532022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2007 GOLD Guidelines: a comprehensive care framework.
    Gold PM
    Respir Care; 2009 Aug; 54(8):1040-9. PubMed ID: 19650945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral infections in patients with chronic obstructive pulmonary disease.
    Varkey JB; Varkey B
    Curr Opin Pulm Med; 2008 Mar; 14(2):89-94. PubMed ID: 18303415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.
    Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y
    Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentially avoidable hospitalizations for COPD and pneumonia: the role of physician and practice characteristics.
    O'Malley AS; Pham HH; Schrag D; Wu B; Bach PB
    Med Care; 2007 Jun; 45(6):562-70. PubMed ID: 17515784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia.
    Jasti H; Mortensen EM; Obrosky DS; Kapoor WN; Fine MJ
    Clin Infect Dis; 2008 Feb; 46(4):550-6. PubMed ID: 18194099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and infection in exacerbations of chronic obstructive pulmonary disease.
    Pietila MP; Thomas CF
    Semin Respir Infect; 2003 Mar; 18(1):9-16. PubMed ID: 12652449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of automated acid-base mapping on diagnose and treatment of community acquired pneumonia in emergency department].
    Yang XF; Wang HR; Gu JH; Jiang J; Pan SM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Oct; 24(10):600-3. PubMed ID: 23040776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbation of chronic obstructive pulmonary disease.
    Ismail TS
    Med J Malaysia; 2009 Sep; 64(3):250-5; quiz 256. PubMed ID: 20527283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.